Drug intelligence / Profile preview

Iodine Tincture USP

Development stage: Unknown
Lead developer: Garima Health Care
Modality: Small Molecules
Administration: Topical

Overview

Iodine Tincture USP, manufactured by Garima Health Care, is a topical antiseptic solution used for the disinfection of skin and the prevention of infection in minor wounds, cuts, scrapes, and burns. It is formulated as a tincture containing 2% elemental iodine and potassium iodide in an alcohol-water base (44-50% alcohol). The mechanism of action involves the release of free iodine, which exerts rapid germicidal activity by inducing oxidative damage to essential microbial cell components, including proteins, nucleotides, and fatty acids, leading to cell death. It is effective against a broad spectrum of bacteria and fungi.

Brand names: Iodine Tincture USP
Other names: Iodine Tincture

Beyond the preview

Go deeper on Iodine Tincture USP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iodine Tincture USP.

Explore the full profile